KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Acquisitions (2016 - 2024)

Historic Acquisitions for Thermo Fisher Scientific (TMO) over the last 16 years, with Q3 2024 value amounting to $3.1 billion.

  • Thermo Fisher Scientific's Acquisitions rose 24455.45% to $3.1 billion in Q3 2024 from the same period last year, while for Dec 2024 it was $3.1 billion, marking a year-over-year decrease of 1442.62%. This contributed to the annual value of $3.1 billion for FY2024, which is 1442.62% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Acquisitions stood at $3.1 billion for Q3 2024, which was up 24455.45% from $909.0 million recorded in Q3 2023.
  • In the past 5 years, Thermo Fisher Scientific's Acquisitions registered a high of $17.9 billion during Q4 2021, and its lowest value of -$1.0 million during Q2 2020.
  • Moreover, its 5-year median value for Acquisitions was $82.0 million (2021), whereas its average is $2.0 billion.
  • Its Acquisitions has fluctuated over the past 5 years, first plummeted by 10106.38% in 2022, then skyrocketed by 9100000.0% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Acquisitions (Quarter) stood at $35.0 million in 2020, then surged by 50974.29% to $17.9 billion in 2021, then tumbled by 100.01% to -$1.0 million in 2022, then soared by 91000.0% to $909.0 million in 2023, then surged by 244.55% to $3.1 billion in 2024.
  • Its Acquisitions stands at $3.1 billion for Q3 2024, versus $909.0 million for Q3 2023 and $47.0 million for Q3 2023.